The healthcare community is excited about the new drug, a dual-action treatment showing significant results in early studies . This new compound, a GLP-1 receptor agonist alongside a GIP molecule , appears to effectively lower body weight and improve metabolic function . Researchers are indicating that it may offer a significant improvement for … Read More